Compliance Man Goes Global-Episode 4-Training
Global Growth: A Prime Opportunity for the Middle Market
Aquila: M&A Looking Up in 2013; "The Negatives Are Built In"
StoneTurn’s Advance in Africa panel hosted by Partner Sarah Keeling, and moderated by renowned journalist Rageh Omaar, brought together leading industry experts to explore investment opportunities in Sub-Saharan Africa. Temi...more
On July 19th, 2023, the Central Committee of the Communist Party of China (CPC) and the State Council jointly released a detailed policy entitled “Opinions on Promoting the Development and Growth of the Private Economy” (the...more
New Government in 2023- On October 30, 2022, former president Luis Inácio Lula da Silva (Lula) was elected as Brazil’s next president. Despite receiving the largest number of votes ever for any candidate in Brazil’s...more
Earlier this month, the United Kingdom’s Green Technical Advisory Group (“GTAG”) published its Advice on the Development of a UK Green Taxonomy (the “Report”). This is the first stage of analysis published by the GTAG and...more
The healthcare and life sciences (HCLS) sector remained particularly active throughout 2020. Despite the COVID-19 pandemic, deal activity was very strong in the first half of the year — with notable transactions including...more
Letter from Our Co-Chairs - As the digital transformation of financial markets accelerates at breakneck speeds, fintech presents significant opportunities and challenges for both investors and innovators around the world. ...more
From the rise of digital health opportunities to concerns stemming from political shifts, McDermott partners review major European health trends in 2019 and look forward to what we might expect to see from 2020 onwards. ...more
In a week that’s already seen plenty of C-suite shakeups, we’ve learned that Ginni Rometty is stepping down from her role as CEO at IBM. The company’s cloud computing chief, Arvind Krishna, will take over for her, though...more
Innovation in the life sciences and health care industries is occurring at a dizzying pace. Five years ago, anti-PD-1 antibodies from Merck and BMS had yet to be approved, CAR-T therapies were still in small-scale clinical...more
The ultra-wealthy are allocating more of their money to equities and less to hedge funds and real estate this year, a survey of family offices published on Wednesday found. Equities accounted for 27.1 percent of the average...more